A new type of coagulation inhibitor.
D000063:Accidents, Traffic; D000740:Anemia / Q000209:etiology*; D001778:Blood Coagulation Disorders / Q000150:complications*; D001780:Blood Coagulation Tests; D001856:Bone Marrow Examination; D005260:Female; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D007084:Iliac Vein; D007106:Immune Sera; D007501:Iron / Q000097:blood; D007503:Iron Isotopes; D007970:Leukopenia; D008099:Liver / Q000473:pathology; D008218:Lymphocytosis; D008259:Macroglobulins / Q000032:analysis; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000188:drug therapy; D009393:Nephritis / Q000139:chemically induced; D010615:Phenacetin / Q000009:adverse effects; D010630:Phenindione / Q000627:therapeutic use; D011516:Prothrombin / Q000037:antagonists & inhibitors*; D011655:Pulmonary Embolism / Q000188:drug therapy; D013163:Splenomegaly; D013921:Thrombocytopenia; D013927:Thrombosis
D007106:Immune Sera; D007503:Iron Isotopes; D008259:Macroglobulins; D010630:Phenindione; D011516:Prothrombin; D006493:Heparin; D007501:Iron; D010615:Phenacetin